Li Hongyan, Sun Li, Brigstock David R, Qi Lina, Gao Runping
Department of Hepatic-Biliary-Pancreatic Medicine, First Hospital, Jilin University, Changchun 130021, Jilin Province, China.
The Research Institute at Nationwide Children's Hospital, Columbus, OH, United States; Division of Pediatric Surgery, Department of Surgery, The Ohio State University, Columbus, OH 43205, United States.
Pathol Res Pract. 2017 May;213(5):565-569. doi: 10.1016/j.prp.2017.01.024. Epub 2017 Feb 10.
IgG4-related sclerosing cholangitis (IgG4-SC) is the biliary manifestation of IgG4-related disease (IgG4-RD) but the presence of IgG4-SC in the porta hepatis is difficult to differentiate from hilar cholangiocarcinoma (HCCA). IgG4-related autoimmune hepatitis (IgG4-related AIH) is extremely rare and it is not fully clear whether IgG4-related AIH is a hepatic manifestation of IgG4-RD or a subtype of AIH.
We present a rare case of a 52-year-old male who was admitted with obstructive jaundice and itchy skin. He primarily presented a severe bile duct stricture in the porta hepatis and an elevated serum level of carbohydrate antigen 19-9 (CA19-9) mimicking HCCA. The patient underwent a surgical resection of the left hepatic lobular and cholecyst as well as common bile duct with a right hepatico-jejunostomy. He was finally diagnosed as IgG4-SC accompanied with IgG4-related AIH by immunohistochemistry, but he lacked conventional autoantibodies. The patient responded well to steroid therapy and remains healthy with no signs of recurrence at six-month follow-up.
This is the first case report that hepatic portal IgG4-SC overlapping with IgG4-related AIH without the presence of conventional autoantibodies. Additionally, we suggest that IgG4-RD should be always considered in case of a bile duct stricture in the porta hepatis to avoid unnecessary surgical operation.
IgG4相关硬化性胆管炎(IgG4-SC)是IgG4相关疾病(IgG4-RD)的胆道表现,但肝门部IgG4-SC的存在难以与肝门部胆管癌(HCCA)相鉴别。IgG4相关自身免疫性肝炎(IgG4相关AIH)极为罕见,IgG4相关AIH究竟是IgG4-RD的肝脏表现还是AIH的一个亚型尚不完全清楚。
我们报告一例罕见的52岁男性患者,因梗阻性黄疸和皮肤瘙痒入院。他主要表现为肝门部严重胆管狭窄及血清糖类抗原19-9(CA19-9)水平升高,酷似HCCA。患者接受了左肝叶、胆囊及胆总管切除并右肝管空肠吻合术。最终通过免疫组化诊断为IgG4-SC合并IgG4相关AIH,但他缺乏传统自身抗体。患者对类固醇治疗反应良好,随访6个月时保持健康,无复发迹象。
这是首例关于肝门部IgG4-SC与IgG4相关AIH重叠且无传统自身抗体的病例报告。此外,我们建议对于肝门部胆管狭窄的病例应始终考虑IgG4-RD,以避免不必要的手术。